[go: up one dir, main page]

DK3360863T3 - Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf - Google Patents

Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf Download PDF

Info

Publication number
DK3360863T3
DK3360863T3 DK16853130.9T DK16853130T DK3360863T3 DK 3360863 T3 DK3360863 T3 DK 3360863T3 DK 16853130 T DK16853130 T DK 16853130T DK 3360863 T3 DK3360863 T3 DK 3360863T3
Authority
DK
Denmark
Prior art keywords
manufacture
etomidate derivative
etomidate
derivative
Prior art date
Application number
DK16853130.9T
Other languages
English (en)
Inventor
Guisheng Zhang
Xiangqing Xu
Liang Ren
Qingeng Li
Tao Wang
Lingguo Zeng
Original Assignee
Jiangsu Nhwaluokang Pharmceutical Res And Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Nhwaluokang Pharmceutical Res And Development Co Ltd filed Critical Jiangsu Nhwaluokang Pharmceutical Res And Development Co Ltd
Application granted granted Critical
Publication of DK3360863T3 publication Critical patent/DK3360863T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16853130.9T 2015-10-10 2016-10-10 Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf DK3360863T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510650913 2015-10-10
PCT/CN2016/101696 WO2017059827A1 (zh) 2015-10-10 2016-10-10 依托咪酯衍生物及其中间体、制备方法和用途

Publications (1)

Publication Number Publication Date
DK3360863T3 true DK3360863T3 (da) 2022-06-13

Family

ID=58487268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16853130.9T DK3360863T3 (da) 2015-10-10 2016-10-10 Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf

Country Status (10)

Country Link
US (1) US10392352B2 (da)
EP (1) EP3360863B1 (da)
JP (1) JP6983416B2 (da)
CN (2) CN113880770A (da)
CA (1) CA3001431C (da)
DK (1) DK3360863T3 (da)
ES (1) ES2913090T3 (da)
HU (1) HUE058909T2 (da)
PL (1) PL3360863T3 (da)
WO (1) WO2017059827A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109748876A (zh) * 2017-11-02 2019-05-14 北京蓝丹医药科技有限公司 依托咪酯衍生物及其制备方法
CN109776510B (zh) * 2018-01-30 2023-08-18 成都麻沸散医药科技有限公司 一种n-取代咪唑甲酸酯类衍生物及其用途
WO2021068943A1 (zh) * 2019-10-11 2021-04-15 成都麻沸散医药科技有限公司 一种取代氮杂环化合物及其麻醉作用
CN116262729A (zh) * 2021-12-15 2023-06-16 燃点(南京)生物医药科技有限公司 一类依托咪酯杂质化合物、制备方法及其应用
CN116265442B (zh) * 2021-12-16 2024-08-06 燃点(南京)生物医药科技有限公司 一种依托咪酯的制备方法
CN119462514B (zh) * 2025-01-16 2025-03-14 四川大学华西医院 依托咪酯衍生物及其制备方法和在制备麻醉药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009251659B2 (en) * 2008-03-31 2013-07-11 The General Hospital Corporation Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
WO2011005969A2 (en) * 2009-07-10 2011-01-13 The General Hospital Corporation Etomidate analogues that do not inhibit adrenocortical steroid synthesis
PL2802325T3 (pl) * 2012-01-13 2017-11-30 The General Hospital Corporation Związki znieczulające i powiązane sposoby zastosowania
CN104706587A (zh) * 2013-12-16 2015-06-17 天津迈迪瑞康生物医药科技有限公司 一种依托咪酯脂肪乳浓缩液、其制备方法及用途
CN103739553B (zh) * 2013-12-23 2014-11-12 四川大学华西医院 含有醚侧链的n-取代咪唑羧酸酯手性化合物、制备方法和用途

Also Published As

Publication number Publication date
JP6983416B2 (ja) 2021-12-17
EP3360863A4 (en) 2019-06-19
ES2913090T3 (es) 2022-05-31
WO2017059827A1 (zh) 2017-04-13
PL3360863T3 (pl) 2022-08-08
US10392352B2 (en) 2019-08-27
HUE058909T2 (hu) 2022-09-28
CA3001431C (en) 2023-09-26
US20180297958A1 (en) 2018-10-18
CN108349906B (zh) 2021-11-02
CA3001431A1 (en) 2017-04-13
CN108349906A (zh) 2018-07-31
EP3360863B1 (en) 2022-04-20
JP2018530611A (ja) 2018-10-18
EP3360863A1 (en) 2018-08-15
CN113880770A (zh) 2022-01-04

Similar Documents

Publication Publication Date Title
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3486242T3 (da) Oxopicolinamidderivat, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf
DK3453707T3 (da) Benzazepinderivat, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3214081T3 (da) Isoindolinderivat, mellemprodukt, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf
DK3303386T3 (da) Anti-Tau-antistoffer og fremgangsmåder til anvendlelse
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3215471T3 (da) Dybe, ubrydelige belastningsprofiler og fremgangsmåde til fremstilling
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
PL3167096T3 (pl) Dwuetapowy sposób nanoszenia
DK3152956T3 (da) Systemer og metoder til kommunikation
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3221912T3 (da) Hidtil ukendte polymerer og fremgangsmåder til fremstilling heraf
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
DK3548033T3 (da) Forbindelser og deres fremgangsmåde til anvendelse
DK3559000T3 (da) Benzimidazol-derivater, fremgangsmåder til fremstilling og anvendelser deraf
DK3161693T3 (da) System og fremgangsmåde til overvågning
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3363183T3 (da) Fremgangsmåde og indretning til dynamisk protokolvalg
DK3368613T3 (da) Matteringsmiddel og fremgangsmåde til fremstilling deraf
DK3178324T3 (da) Mikrobicid og fremgangsmåde til fremstilling af samme
DK3258809T3 (da) Smykkeelement og fremgangsmåde til fremstilling heraf
DK3347310T3 (da) Afsaltningsprocesser og fremgangsmåder til gødningsproduktion